The synthesis of tritiated (R)-2-methoxy-N-n-propyl-nor-apomorphine (MNPA)
✍ Scribed by Jonas Malmquist; Susanne Olofsson; Peter Ström
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- French
- Weight
- 104 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A method for the preparation of [^3^H]‐MNPA ((R)‐2‐methoxy‐N‐n‐propyl‐norapomorphine) has been developed addressing the regioisomer problem as well as the oxidation problem. (R)‐2, 10, 11‐trihydroxy‐N‐n‐propyl‐norapomorphine was protected with 10, 11‐dibenzyl or 10, 11‐acetonide. The pure precursor was then methylated using [^3^H]‐methyliodide. The product was isolated after deprotection and high‐pressure liquid chromatography (HPLC) purification. Ascorbic acid was used as an antioxidant in the HPLC eluent and the stock solution. Characterization of the intermediates and products with ^3^H‐ and ^1^H‐NMR was performed. A specific activity of 3.1 TBq/mmol (83.8 Ci/mmol) and 98.9% purity was obtained. Copyright © 2007 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract Amino acids with __N__‐alkylaminooxy side chains have proven effective for the rapid synthesis of neoglycopeptides. Chemoselective reaction of reducing sugars with peptides containing these amino acids provides glycoconjugates that are structurally similar to their natural counterparts.
The present study was designed to characterize the dopamine D 3 receptor agonist R()-7-hydroxy-N,N-di-n-propyl-2-aminotetralin (R()-7-OH-DPAT)-induced changes in locomotor activity in mice. Although R()-7-OH-DPAT (0 . 01±10 mg/kg) produced a signi®cant decrease in horizontal and vertical motility wi